







































Over 200 million people worldwide, ranging from 20 to 
79 years in age, suffer from diabetes mellitus, typically 
the late onset type 2 diabetes (T2D) [1, 2]. By 2025, this 
number is projected to rise to over 300 million 
propelled by the aging of the population. Thus, new 
treatments for T2D, including approaches to address 
progressive pancreatic beta cell insufficiency, are 
needed.  
 
Competent for multilineage differentiation, embryonic 
stem (ES) cells are regarded potentially promising for 
regenerative  applications.   Differentiation  of  ES  cells  
 
 







































into transplantable tissues could lead to repair therapies 
for severe degenerative diseases, including diabetes. In 
preclinical studies, human ES cells have been 
differentiated into insulin-producing cells [3-5], which 
can reverse the course of diabetes [3]. However, ES cell 
use is associated with ethical issues and further limited 
by allogeneic mismatch, restricting clinical application.  
Recently established nuclear reprogramming metho-
dologies allow generation of autologous pluripotent 
stem cells from somatic sources. Ectopic expression of 
primordial transcription factors [6-10] dedifferentiates 
adult somatic tissue into induced pluripotent stem (iPS) 
cells. In general, iPS cells share similar properties with 
ES cells with respect to morphology, growth, 











































reprogramming  of  keratinocytes  ensures  a  senescence‐privileged  status  yielding  iPS  cells  proficient  for  regenerative
applications.  
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renewal and multilineage potential [11]. Analysis of 
global gene expression profiles of human iPS cells has 
also revealed patterns similar to those of human ES 
cells, with notable upregulation of pluripotency-
associated genes [12, 13]. Similar to ES cells, human 
iPS cells can be induced to differentiate into various cell 
types, including insulin-producing cells [14-17], as well 
as tissues associated with T2D complications such as 
neurons [18] and heart muscle [19-21]. Diverse somatic 
sources have been successfully reprogramed, including 
fibroblasts, stomach and liver cell cultures [22], and 
blood cells including mature B and T lymphocytes [23]. 
Moreover, human keratinocytes [24, 25] are a 
promising resource for clinical-grade iPS derivation. 
Indeed, efficient and rapid iPS derivation from 
keratinocytes has been demonstrated from a 4 year-old 
child and 28-35 year-old young adults [25]. Disease-
specific iPS derivation has been also reported from 
young adults with various genetic or degenerative 
diseases, including generation of iPS cells from type 1 
diabetes (T1D) [14, 26]. However, to date, derivation of 
iPS cells from T2D patients has not been documented. 
Moreover, it remains uncertain whether advanced age 
compromises cellular reprogramming.  
 
Here, we examined the feasibility of iPS derivation 
from epidermal keratinocytes from elderly T2D 
patients, analyzed molecular and cellular events 
associated with nuclear reprogramming, and determined 
differentiation propensities of derived pluripotent cells. 
Keratinocytes from T2D patients offered a reproducible 
source for patient-specific iPS generation, proficient in 
yielding insulin-producing islet-like progeny, through 




Reprogramming of human keratinocytes 
 
Lentiviral vectors encoding human OCT4, SOX2, KLF4 
and c-MYC, at an approximate multiplicity of infection 
of 5 each, transduced early passage human kera-
tinocytes (HK cells) derived from 56 to 78 year-old 
individuals with or without T2D. Under serum-free and 
feeder-free conditions, within 1 to 2 weeks after viral 
vector infection, small reprogrammed colonies, 
characterized by a sharp-edged, flat, tightly-packed 
morphology, were apparent (Figure 1A). Individual 
colonies were picked based on size and morphology at 3 
to 5 weeks after viral transduction, and expanded. 
Structurally derived clones resembled human ES or 
fibroblast-derived iPS cells, and expressed high levels 
of the stemness marker alkaline phosphatase (Figure 
1B). Immunocytochemistry further validated robust 
expression of diverse pluripotency markers, including 
SSEA-4, TRA-1-60, TRA-1-81, OCT4, SOX2, KLF4 
and NANOG in HK-derived iPS clones regardless of 
patient age and status of diabetes (Figure 1C). The 
obtained yield was 2 to 10 expandable clones per 10
5 
transduced cells with maintained pluripotent markers 
and absence of replicative crisis even at 7 months post-
initial vector infection (up to passage 60). 
 
Differentiation propensity of derived iPS cells  
 
HK-derived iPS clones from diabetic and non-diabetic 
patients spontaneously differentiated in vitro into cells 
of all three germ layers within embryoid body (EB) 
formations (Figure 2). In line with acquired 
pluripotency, HK-derived iPS cells differentiated into 
ectoderm (beta-III tubulin), endoderm (FOXA2) and 
mesoderm (CD31) as detected by immunostaining for 
lineage-specific markers (Figure 2A). Of note, clonal - 
rather than inter-patient - variations in differentiation 
propensities were observed within the tested cohort 
(Figure 2A). Moreover, in vivo, HK-derived iPS cells, 
transplanted under the kidney capsule of SCID-beige 
mice at a dose of 1 million cells, gave rise to 1-2 cm 
outgrowth within 4 weeks (Figure 2B). Tissue histology 
revealed iPS differentiation into mesoderm lineages 
indicated by muscle and adipocytes (Figure 2C), 
ectoderm lineages denoted by neuroepithelium-like 
tissues (Figure 2C), and endoderm lineages composed 
of glandular tissue (Figure 2C). These data document 
multilineage propensity of HK-derived iPS cells from 
both diabetic and non-diabetic patients across tested age 
groups. 
 
Genome-wide transcriptome switch underlies 
transition to induced pluripotency 
 
Unbiased scan of the genome-wide transcriptome 
revealed distinct global gene-expression patterns in 
parental HK versus HK-derived iPS clones (Figure 3). 
The dendrogram of unsupervised one-way hierarchical 
clustering analysis demonstrated that HK-derived iPS 
cells from different patients clustered together, and 
branched out from its parental origin (Figure 3A). 
Consistent with the acquisition of a pluripotent 
transcriptome, gene expression patterns of HK-derived 
iPS cells were overall similar to those of human ES H9 
cells, and different from parental counterparts (Figure 
3B). Induction of key pluripotency genes, such as 
OCT4, SOX2, NANOG, LIN28, telomerase (TERT), 
DPPA4 and PODXL, were also evident in iPS clones 
(Figure 3C). Further analysis revealed upon 
reprogramming significantly up-regulated proto-
oncogenes (N-MYC and KIT), pluripotency-
maintenance factor FGF-2 and  the  receptor for FGF-2  
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genes were down-regulated across HK-derived iPS 
clones (Figure 3D). Similar to ES cells, which are 
known to express minimal levels of MHC class I 
genes, HK-derived iPS cells showed marked down-
regulation of these genes (Figure 3E). Bioinformatic 
analysis of transcriptome data identified pathways 
involved in epithelial-to-mesenchymal transition and 
cytoskeletal remodeling as most significantly affected 
networks in response to reprogramming of HK cells, in 
line with genuine redirection of cell fate (data not 
shown). No notable difference was observed in the 
transcriptome of iPS clones from non-diabetic and 
diabetic patients. 
 
Ultrastructural remodeling induced by repro-
gramming 
 




































the size of derived iPS compared to parental HK (Figure 
4). Parental HK cells were 25 to 40 µm in diameter, 
while derived iPS cells were 10 to 15 µm, characterized 
by scant cytoplasm and regularly condensed chromatin 
(Figure 4A) with frequent mitotic events (Figure 4B). 
The cytosol of HK cells was densely packed with 
membrane-bound organelles (Figure 4C, left panel) and 
keratin intermediate filaments. In sharp contrast, widely 
distributed, relatively poorly developed endoplasmic 
reticulum and Golgi stacks were found in iPS clones 
(Figure 4C, right panel). In HK cells, mitochondria 
appeared mainly tubular-shaped and showed well-
developed cristae. In contrast, mostly globular immature 
mitochondrial remnants, characterized by unorganized 
cristae, were found in HK-derived iPS cells (Figure 4D) 
as in verified fibroblast-derived iPS clones [16, 27] 
(Figure 4A). No notable difference was observed in 
morphologies of mitochondria between iPS clones from 


























































































Reprogramming down-regulates mitochondria/ 
oxidative stress signaling pathway 
 
The copy number of mitochondrial DNA before and 
after reprogramming showed a 30 to 60% reduction in 
the abundance of mitochondrial DNA in iPS compared 
to HK cells (Supplementary Figure S1). Immuno-
staining with mitochondrial probes detected 
mitochondria-specific signals in individual iPS cells 














































expression of nuclear-encoded mitochondrial biogenesis 
factors (Supplementary Figure S1). Selected genes 
involved in the TCA cycle, such as ACO2, SDHA and 
FH, were down-regulated by nuclear reprogramming 
(Supplementary Figure S1). Transcriptome analysis 
further revealed that genes encoding the mitochondrial/ 
oxidative stress response pathway are highly expressed 
in HK cells from elderly patients, yet markedly down-
regulated in derived iPS cells (Supplementary Figure 
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[28], such as catalase CAT and GPX1 (Supplementary 
Figure S1), suggesting reversal of senescence cellular 
markers.  
   
Reprogramming induces telomere elongation and 
down-regulates genes involved in senescence 
 
RT-PCR verified increased levels of TERT-specific 
transcripts in HK-derived iPS cells (Figure 5A). In fact, 
the telomere restriction fragment (TRF) assay further 
demonstrated that HK-derived iPS cell lines display 
longer telomeres than parental HK cells (Figure 5B), 









































regardless of diabetes status. Comparison of the 
transcriptome between three parental HK cells (SW3-
HK, SW4-HK and SW8-HK) and derived iPS clones 
(SW3 #B, SW4 #N1 and SW8 #20I) revealed 
significant down regulation (p < 0.05) of 
senescence/apoptosis-associated genes (Figure 5C), 
including p16
INK4a and p15
INK4b in the p16
INK4a/RB 
pathway, and p21
CIP1 in the p19
ARF/p53 pathway, and 
proapoptotic genes, including FAS, CASP8, CASP7, 
BAD and TP53AIP1 (Figure 5D). Thus successful 
cellular reprogramming of somatic cells from elderly 
patients is associated with suppression of key 
senescence- and apoptosis-related pathways in diabetic 


































































































Proficiency of HK-derived iPS cells to yield insulin-
producing islet-like progeny 
 
HK-derived iPS clones were initially induced to form 
definitive endoderm by treatment with activin A and 
Wnt3a for 1 day followed by culture in activin A and 
2% FBS for 4 additional days. Immunostaining revealed 
efficient induction in iPS-derived cells of SOX17 and 















































Similar results were observed with iPS clones generated 
from diabetic or non-diabetic patients. Next, we 
evaluated the efficiency of definitive endoderm 
transformation into pancreatic endoderm. As shown in 
Figure 6B, prominent nucleus-localized signals for 
pancreatic endoderm, namely PDX1 and NKX6.1, were 
found in iPS-derived cells at day 14 of differentiation. No 
notable difference was found among iPS clones from 
non-diabetic and diabetic patients. These results indicate 
Figure 5. Comparison of telomerase activity, cellular senescence and programmed cell death in
HK  cells  before  and  after  induced pluripotency.  (A)  RT‐PCR  analysis  of  TERT‐specific  transcripts  in
parental HK cells and iPS clones. GAPDH was used as control. (B) Telomere lengths in HK and HK‐derived iPS
cells were determined by the terminal restriction fragment lengths. Southern blot analysis and corresponding
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iPS-derived definitive endoderm. In the presence of 
DAPT and GLP-1, iPS-derived pancreatic endoderm 
cells were further differentiated for 6 days, followed by 
maturation in HGF, IGF-1, and GLP-1 for additional 8 
days. By day 24, insulin-producing cells were 
sporadically detected in iPS-derived progeny (Figure 
6C), while more prominent immunostaining for insulin 
evident after final maturation at day 29 (Figure 6D and 













































insulin and PDX1, the majority of iPS-derived insulin-
expressing cells showed nuclear-localized PDX1 signals 
(Figure 6D and E). High levels of intracellular C-peptide 
(250-290 pM), a byproduct of proinsulin protein process-
sing, were detected in iPS progeny by ELISA, while RT-
PCR revealed positive gene expression of key pancreatic 
factors, including insulin (INS), glucagon (GCG) and 
somatostatin (SST), and glucose transporter 2 (GLUT2) 
(Figure 6F). Thus, HK-derived iPS cells differentiate into 
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The present study reports derivation of iPS cells from 
T2D patients. Human keratinocytes provided the 
starting somatic tissue reprogrammed here, under 
serum/feeder-free conditions, into genuine pluripotent 
derivatives proficient in generating insulin-producing 
islet-like progeny. Dedifferentiation of epidermal 
keratinocytes from elderly patients was driven by 
induction of stemness transcription factors, and 
associated with suppression of senescence/apoptosis 
gene sets. Lineage specification mimicked natural 
pancreatic development encompassing staged 
differentiation from definitive endoderm to hormone-
producing islet-resembling phenotype. Thus, derivation 
of proficient iPS cells from elderly T2D patients is 
feasible, expanding the spectrum of disease entities 
amenable to somatic cell fate redirection.   
 
To date, disease-specific iPS cells have been established 
from a series of diverse human disease conditions, 
including amyotrophic lateral sclerosis, type 1 diabetes, 
Huntington’s and Parkinson’s disease, muscular 
dystrophy, Fanconi anemia, Down syndrome, 
dyskeratosis congenita and gyrate atrophy [14, 26, 29-
34]. It is notable that iPS cells from patients with spinal 
muscular atrophy, familial dysautonomia and 
LEOPARD syndrome recapitulated the respective 
disease phenotypes upon redifferentiation [35-37], 
underscoring the value of derivation of patient-specific 
iPS cells for disease modeling and molecular 
diagnostics. Although T2D is one of the most prevalent 
degenerative diseases, derivation of T2D-specific iPS 
cells has not yet been documented. Moreover, the 
impact of aging on nuclear reprogramming remains 
elusive. Here, we demonstrate feasibility and 
reproducibility of iPS derivation from elderly T2D 
patients, extending the disease-specific collection of 
validated human iPS clones. The uniqueness of T2D 
among human degenerative diseases is the high 
prevalence within an exponentially growing elderly 
population and association with complications across 
distinct tissue types including severe retinopathy, 
nephropathy, neuropathy and cardiovascular diseases. 
T2D-specific iPS cells, derived herein, would thus 
provide a previously unavailable platform to study the 
mechanisms of T2D progression and T2D-associated 
complications. 
 
Surgical skin specimens provided herein epidermal 
keratinocytes used as the somatic source for efficient 
and rapid iPS derivation. Epidermal keratinocytes have 
been used for skin transplant, and more recently 
proposed as a source for bioengineering pluripotent 
stem cells following the successful reprogramming from 
normal human foreskin or plucked hair from children or 
young adults [25]. In addition to the inherently high 
expression of selective stemness genes c-MYC and 
KLF4 which may facilitate cell fate redirection, 
keratinocytes were amenable here to culture in xeno-
free systems, and responsive to feeder-free 
reprogramming, rendering HK cells a robust source for 
iPS derivation from elderly T2D patients. 
 
Studies have established that cellular senescence 
impairs nuclear reprogramming in murine primary 
cultures [38-40] or human cell lines [39, 41]. 
Accordingly, somatic cells from old mice are resistant 
to reprogramming compared to young mice [39). 
Conversely, siRNA-mediated inhibition of p16
INK4a, 
p19
Arf or p53 improves reprogramming efficiency [38-
40, 42]. Moreover, genetic ablation of p16
INK4a or p53 
or immortalization with TERT overexpression 
significantly improves reprogramming efficiency [38, 
40]. Present data revealed that reprogramming of HK 
cells from elderly patients is accompanied with 
telomere elongation and suppression of senescence- and 
apoptosis-related genes, suggesting induction of a 
rejuvenated state, in line with successful derivation of 
IPS cells from elderly individuals [30]. Marked 
suppression of p16
INK4a, but not p19
ARF, in HK-derived 
iPS cells supports the notion that p16
INK4a, rather than 
p19
ARF, is a main regulator of reprogramming in human 
cells [39]. Since a 20-fold down-regulation of p21
CIP1 
was found in HK-derived iPS cells, it could be 
speculated that the p19
ARF/p53 senescence pathway is 
suppressed at the p21
CIP1 stage, rather than at p19
ARF. 
Although we were successful in generating iPS cells 
from elderly patients, it is plausible that RNAi-mediated 
down-regulation of p16
INK4a, p21
CIP1, and/or CASP8 in 
HK cells could further improve iPS derivation 
efficiency. In addition, we also found broad suppression 
of genes involved in the senescence-related, 
mitochondrial/oxidative stress pathway in HK-derived 
iPS cells. Overall, the present results imply an induced 
state of rejuvenation in iPS cells derived from elderly 
patients, with the Ink4a/Arf/p53 signaling critical for 
somatic cell reprogramming.  
 
A promising strategy to overcome shortage of 
transplantable islet cells is to generate insulin-secreting 
cells from patient-derived iPS cells [43). Here, through 
guided differentiation with ILV and GLP-1, we 
differentiated HK-derived iPS cells into insulin-
producing cells in vitro. This is the first report 
demonstrating successful generation of insulin-
producing cells from T2D-specific iPS cells. Of note, 
p16
INK4a induces an age-dependent decline in islet 
regenerative potential [44]. Transgenic mice with 
overexpressed p16
INK4a show decreased islet 
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observed in p16
INK4a-deficient old mice [44]. Given the 
suppression of senescence-related genes, including 
p16
INK4a, in HK-derived iPS cells observed here, the use 
of iPS cells for islet regeneration appears to be a 
rational strategy, especially for autologous cell therapy 
for elderly patients.  
 
In summary, we demonstrate the feasibility and 
reproducibility of iPS cell derivation from elderly 
patients with T2D. Reprogramming of HK cells was 
accompanied by morphological changes, induction of 
endogenous pluripotency genes, telomere elongation, 
and down-regulation of senescence- and apoptosis-
related genes. Notably, stepwise differentiation with 
ILV and GLP-1 achieved successfully differentiation of 
T2D-specific iPS cells into insulin-producing islet-like 
cells. Thus, reprogramming of keratinocytes from 
elderly T2D patients yields proficient iPS cells through 
induction of a senescence privileged status. T2D-
specific iPS cells would provide a versatile platform for 




Protocols approved by Mayo Clinic Institutional 
Review Board and Institutional Animal Care and Use 
Committee.  
 
Human keratinocytes. Skin specimens from surgical 
pathology from non-diabetic and type 2 diabetic (T2D) 
individuals were enzymatically processed.  Using sterile 
techniques, skin samples were incubated overnight at 
4ºC in dispase (25 U/ml) to cleave epidermis from 
dermis. The epidermal layer was then placed into a 
recombinant trypsin/EDTA solution (Invitrogen, 
Carlsbad, CA,) and incubated for 30 min at 37ºC. 
Trypsin/EDTA was neutralized with a trypsin inhibitor 
(Invitrogen, Carlsbad, CA) and epidermal pieces 
pipetted to release epidermal cells. The suspension was 
then passed through a 70 µm cell strainer and pelleted. 
Cell viability was determined by the trypan blue 
exclusion method. Cells were seeded in a plate coated 
with an animal component-free (ACF) coating matrix 
(Invitrogen). Selective trypsinization removed 
fibroblasts at ~6 min, while human keratinocytes (HK) 
were dissociated at ~20 min. HK cell populations were 
then grown in EpiLife Medium and S7 growth 
supplement (Invitrogen, Carlsbad, CA) in 5% CO2 and 
95% air at 37ºC. HK cells were maintained semi-
confluent in low calcium media.  
 
Reprogramming. Lentiviral vectors, pSIN-OCT4, pSIN-
SOX2, pSIN-KLF4 and pSIN-cMYC were 
manufactured as previously described to express 
pluripotency factors from an internal spleen focus-
forming virus (SFFV) promoter [45]. HIV vectors were 
produced by transient transfection of 293T cells. To 
minimize calcium-mediated differentiation of HK cells 
during vector infection, lentiviral vectors were 
concentrated by ultracentrifugation and re-suspended in 
PBS [46]. Lentiviral titers were determined by 
immunostaining [45]. Human HK cells were grown in 
vitro in ACF EpiLife Medium in a matrix-coated plate. 
Cultures were transduced overnight with human OCT4, 
SOX2, KLF4 and cMYC expressing lentiviral vectors 
[45). Culture supernatants were replaced daily with 
ACF media. At 4 days after vector infection, media was 
changed to HEScGRO medium (100 ml, Millipore, 
Billerica, MA) supplemented with mTeSR-1 
maintenance media (25 ml, Stemcell Technologies, 
Vancouver, BC, Canada) [16]. One to two weeks after 
vector infection, reprogrammed cells began to form 
colonies displaying stem cell morphology [16]. At   
three to four weeks after vector infection, cultures were 
treated with Cell Dissociation Buffer (Invitrogen, 
Carlsbad, CA) for 5 to 10 min to help lift clones picked 
by a P200 pipette, and placed in BD Matrigel (BD 
Biosciences, San Jose, California) coated 96-well 
plates. To prevent spontaneous differentiation, the iPS 
culture medium was replaced daily and differentiated 
cells in cultures manually removed. As clones grew, 
cultures were expanded into larger culture plates for 
further characterization. iPS clones were preserved 
using Xeno-FREEze™ Human Embryonic Stem Cell 
Freezing Medium (Millipore, Billerica, MA). For 
spontaneous differentiation, iPS clones were dissociated 
using collagenase IV (Stemcell Technologies) for 30 
min and plated on low adhesion plates in basal 
HEScGRO medium without bFGF. Embryoid bodies 
(EBs) were cultured as suspensions for 7-14 days, and 
grown adherent in DMEM with 20% FBS for additional 
7-14 days. 
 
Differentiation of iPS cells into insulin-producing cells. 
iPS clones were treated with 25 ng/ml Wnt3a (R&D 
systems) and 100 ng/ml activin A (Peprotech) in 
advanced RPMI (Invitrogen) with Pen/Strep for 1 day, 
followed by treatment with 100 ng/ml activin A in 
advanced RPMI supplemented with 0.2% fetal calf 
serum (FCS) (Invitrogen) for two days. Next, cells were 
cultured in high glucose DMEM (Invitrogen), 
supplemented with 20% (v/v) advanced RPMI medium 
containing 50 ng/ml FGF10 (R&D systems), 0.25 µM 
KAAD-cyclopamine (CYC), and 2% FCS for 2 days. 
Cells were then treated with 50 ng/ml FGF10, 0.25 µM 
CYC, and 2 µM all-trans Retinoic Acid (RA) (Sigma) 
in high glucose DMEM (Invitrogen) supplemented with 
20% advanced RPMI, Pen/Strep, 1x B27 supplement 
(Invitrogen) for 4 days. Cells were then cultured in 50 
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(Sigma) in DMEM (high glucose) supplemented with 
20% advanced RPMI and 1x B27 for 4 days. 
Differentiation medium including 10 µM DAPT 
(Sigma) and 55 nM GLP-1 in DMEM (high glucose) 
with 20% advanced-RPMI and 1x B27 was used to 
culture cells for the next 6 days. Finally, cells were 
cultured in 50 ng/mL hepatocyte growth factor (HGF) 
(R&D systems), 50 ng/ml insulin-like growth factor 1 
(IGF-1) (R&D systems) and 55 nM GLP-1 in CMRL-
1066 medium (Invitrogen) with 1 x B27 for 8 days.  
 
Immunostaining. For immunostaining, iPS cells were 
fixed for 20 min at room temperature (RT) in 4% 
paraformaldehyde (PFA), washed in PBS and blocked 
for 30 min in 5% FBS PBST (PBS with 0.1% Tween-20 
(Sigma) and 5% FBS). Cells were stained with primary 
antibodies overnight at 4°C, rinsed by PBS, and 
incubated with secondary antibodies for 1 h at room 
temperature. Separately, cells at different stages of 
differentiation were fixed and stained with primary and 
secondary antibodies. Primary and secondary antibodies 
used for characterization were: SSEA-1, SSEA-4, TRA-
1–60 TRA-1-81 (Millipore #SCR001), OCT4 (Cell 
Signaling Technology #2750), SOX2 (Cell Signaling 
Technology #2748), KLF4 (Abcam #ab26648) and 
NANOG (Abcam #ab21624), anti-SOX17 (R&D 
Systems #MAB1924), anti-HNF3 beta/FOXA2 
(Millipore #07-633), anti-PDX1 (Santa Cruz 
Biotechnology#sc-25403 and Abcam #ab47267), and 
anti-insulin (Sigma # I2018). Texas Red-conjugated 
anti-rabbit IgG (Jackson Laboratories # 711-075-152), 
Texas Red-conjugated anti-mouse IgG (Jackson 
Laboratories # 715-075-151), FITC-conjugated anti-
rabbit IgG (Jackson Laboratories # 711-095-152), and 
FITC-conjugated anti-mouse IgG (Jackson Laboratories 
# 715-095-151) were used as secondary antibodies. 
DAPI was used to counter-stain nuclei. Stained cells 
were analyzed using confocal laser-scanning 
microscopy (Zeiss, LSM 510 confocal scanning laser 
system).  Alkaline phosphatase staining was performed 
with an Alkaline Phosphatase Detection Kit (Millipore). 
Antibodies FOXA2 for endoderm, beta III tubulin 
(Abcam # ab41489) for ectoderm and CD31 (Santa 
Cruz Biotechnology # sc-1506) for mesoderm were 
used to immunostain embryoid body-derived cells. 
 
In vivo differentiation of iPS cells.  SCID-beige mice 
were anesthetized, and the kidney exposed for iPS 
transplantation under the kidney capsule. To this end, a 
small incision was made in the kidney capsule and a 
blunt needle was used to create a pocket under the 
kidney capsule. Following iPS cell injection, the kidney 
was placed back into the abdomen, and the incision 
closed. Mice were maintained for 4 weeks and 
sacrificed for harvesting normal and iPS-transplanted 
kidneys. OTC-embedded frozen tissues were cryo-
sectioned for H&E staining. 
 
Gene expression.  For amplification of mitochondrial 
DNA, mitochondria-specific primer pairs (CYTB, 
CCTAGCCATGCACTACTCACCAGACGCCT, CTG 
TCTACTGAGTAGCCTCCTCAGATTC; and NADH, 
TCACCAAAGAGCCCCTAAAACCCGCCACATCTA, 
TAAGGGTGGAGAGGTTAAAGGAGC) were used. 
For RT-PCR analysis, total RNA was isolated using 
TRIzol (Invitrogen) and reverse transcription was 
performed with oligo (dT) primer using RNA to cDNA 
EcoDry (Clontech). Platinum Taq DNA polymerase 
(Invitrogen) and primer pairs for TERT 
(TGTGCACCAACATCTACAAG,  GCGTTCTTGGCT 
TTCAGGAT), INS (AGCCTTTGTGAACCAACACC, 
GCTGGTAGAGGGAGCAGATG), SST  (GTACTTCT 
TGGCAGAGCTGCTG, CAGAAGAAATTCTTGCAG 
CCAG), GCG (AGGCAGACCCACTCAGTGA, 
AACAATGGCGACCTCTTCTG),  GLUT2  (GCTACC 
GACAGCCTATTCTA,  CAAGTCCCACTGACATGA 
AG) and α-tubulin (AAGAAGTCCAAGCTGGAGTTC, 
GTTGGTCTGGAATTCTGTCAG) were used for the 
reaction. Separately, total RNA was isolated using 
TRIzol (Invitrogen) and further purified using RNeasy 
Plus spin columns (QIAGEN). Turbo DNA-free DNase 
(Ambion, Austin, TX) was used to digest all genomic 
DNA that could lead to false positive gene expression 
results. RNA quantity and purity were measured with a 
Nanodrop spectrophotometer (Thermo Scientific, 
Wilmington, DE) and RNA integrity was determined 
using the Agilent 2100 Bioanalyzer (Santa Clara, CA). 
Microarray analysis was performed using the Affymetrix 
HG-U133 Plus2 GeneChip Array platform (Affymetrix, 
Santa Clara, CA). Data were preprocessed using 
MicroArray Pre-Processing workflow and hierarchical 
clustering was performed by Pearson Dissimilarity. For 
comparison of transcriptome data between pre- and post-
reprogramming, the data set of parental HK cells from 
three patients (SW3, SW4 and SW8) were compared 
with those of three iPS clones from the same patients 
(SW3 #B, SW4 #N1 and SW8 #20I). Student’s t-test was 
performed to assess significance (p<0.05) in normalized 
gene expression levels between HK and HK-derived iPS 
clones. The Heatmap Builder software (kindly provided 
by Dr. Euan Ashley, Stanford University) was used to 
generate the heatmap for the transcriptome data set. 
Enrichment analysis was also performed to match gene 
IDs in functional ontologies. The registered GEO 
transcriptome information (GSM551202, human ES H9 
cell transcriptome) was used as reference. 
 
Telomere assay. Total genomic DNA was isolated from 
patient-derived HK and iPS cells using QIAGEN 
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determined using TeloTAGGG telomere length assay 
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Supplementary  Figure  S1. Mitochondrial  and 
oxidative‐stress  response  gene  expression  in
induced  pluripotency.  (A)  Relative  cytochrome  B 
(CYTB)  and  NADH  mitochondrial  DNA  (mtDNA)  copy 
numbers  before  (parental)  and  after  (iPS) 





#N1  and  SW10  #5P  with  MitoTracker  (Molecular 
Probes) staining. (D) Heatmap demonstrating up (red)
and  down‐regulation  (green)  of  genes  involved  in





and  HK‐derived  iPS  cells.  Statistically  significant
changes  are  indicated  by  asterisks  (p<0.05).  (F)  RNA 
expression  profiles  of  genes  involved  in  the 
mitochondrial/oxidative  stress  response  pathway 
between  parental  HK  and  iPS  cells  are  shown. 
Statistically  significant  changes  are  indicated  by 
asterisks (p<0.05). 
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